Information sur le laboratoire
Sasha Bernatsky (M.D./Ph.D.)
Scientifique séniorCentre de recherche évaluative en santé
Département de médecine (McGill)
Profil de recherche
Mots-clés
Pharmacoépidémiologie • Lupus érythémateux disséminé • Maladie rhumatismale • Innocuité et efficacité des médicaments • Pollution atmosphériqueIntérêts de recherche
Mes recherches portent principalement sur les conséquences des maladies rhumatismales, la pharmacoépidémiologie et les effets de la pollution atmosphérique sur la santé.Membre de l'équipe
| Nom | Poste |
|---|
Dernières publications
- Stein, O. A., Lee, J. L., Vinet, E., Mendel, A., Pineau, C. A., Kalache, F., Grenier, L.-P. & Bernatsky, S. (2026). Artificial Intelligence-based Online Symptom Assessment Tools for Systemic Lupus Erythematosus (SLE) diagnosis: Patient Perspectives. Arthritis care & research.
- Farhat, R., Zamora-Medina, M. D. C., Bae, S.-C., Barber, M. R. W., Clarke, A. E., Fortin, P. R., Touma, Z., Laskin, C. A., Malhamé, I., Sebastiani, G., Peschken, C., Ugarte-Gil, M. F., Legge, A., Bernatsky, S. & Vinet, É. (2026). Increased Risk of Intrahepatic Cholestasis of Pregnancy in Women With Systemic Lupus Erythematosus Exposed to Azathioprine. Arthritis & rheumatology (Hoboken, N.J.).
- Barber, M. R. W., St Pierre, Y., Peschken, C. A., Legge, A., Hanly, J. G., Vinet, E., Pineau, C. A., Bernatsky, S., Touma, Z., Urowitz, M. B., Gladman, D. D., Fortin, P. R. & Clarke, A. E. (2026). Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort. Lupus science & medicine, vol. 13.
- Flatman, L. K., Beauchamp, M.-E., St-Pierre, Y., Malhamé, I., Bérard, A., Bernatsky, S. & Vinet, É. (2026). Diarrhoea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study. Rheumatology (Oxford, England), vol. 65.
- Kaddoura, R., Bernatsky, S., Beauchamp, M.-E., Guerra, S. F., Almeida-Brasil, C. C., Hanly, J. G., Urowitz, M., Clarke, A. E., Ruiz-Irastorza, G., Gordon, C., Ramsey-Goldman, R., Petri, M. A., Ginzler, E. M., Wallace, D. J., Bae, S.-C., Romero-Diaz, J., Dooley, M.-A., Peschken, C., Isenberg, D., Manzi, S., Jacobsen, S., Lim, S. S., Nived, O., Jönsen, A., Kamen, D. L., Aranow, C., Sánchez-Guerrero, J., Gladman, D. D., Fortin, P. R., Alarcón, G. S., Merrill, J. T., Kalunian, K., Ramos-Casals, M., Zoma, A. A., Askanase, A. D., Khamashta, M., Bruce, I. N., Inanc, M., Lukusa, L. & Abrahamowicz, M. (2026). Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus. Journal of clinical epidemiology, vol. 195, p. 112261.
- Barreth, N., Leclair, V., Hudson, M., Bernatsky, S., Krustev, E., Moran Toro, C., St Pierre, Y., Clarke, A., Sciore, P. J. A., Tarnopolsky, M., Fritzler, M. J., Choi, M. Y. & Canadian Inflammatory Myopathy Study (2026). Soluble SIGLEC1 as a biomarker of disease activity in idiopathic inflammatory myopathies. Rheumatology (Oxford, England), vol. 65.
- Elsayed, M., Hsu, Z., McAlister, F. A., Leslie, W. D., Lix, L. M., Bernatsky, S., Morin, S. N., Graham, M. M., Fifi-Mah, A., Jamal, S., Roberts, J. & Ye, C. (2026). Validation of International Classification of Diseases Code-Based Case Definitions of Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis From Administrative Health Data. Arthritis & rheumatology (Hoboken, N.J.).
- Moura, C. S., Etingin, A., Lukusa, L., Singh, H., Narula, N., Targownik, L. E., Leung, Y., Zezos, P., Polewiczowska-Nowak, B., Afif, W. & Bernatsky, S. (2026). Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars. World journal of gastroenterology, vol. 32, p. 114580.
- Stein, O. A., Lee, J. L. F., Vinet, E., Mendel, A., Pineau, C. A., Kalache, F., Grenier, L.-P., Mielczarek, L. & Bernatsky, S. (2026). Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus. Rheumatology international, vol. 46, p. 34.
- Randall, J. R., Martins, K., Luu, H., Vu, K., Missaoui, H., Fernandez, S., Morrison, S., Stock, D., de Léséleuc, L., Liu, Z., Manning, D., Cheung, G., Moura, C. S., Birck, M. G., Amoozegar, F., Dutton, D. J., Kaboré, J.-L., Bernatsky, S. & Klarenbach, S. W. (2025). Calcitonin Gene-Related Peptide Inhibitor Use in 2018-2023: A Retrospective Cohort Study Across Six Canadian Provinces. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, p. 1-10.
Voir aussi
